Carrick Therapeutics Funding: $60M Raised, Series C (2022)
Carrick Therapeutics is based in Dublin, Ireland. It has raised $60M in total funding. Latest round: Series C.
Carrick Therapeutics funding overview
Carrick Therapeutics is based in Dublin, Ireland. Carrick Therapeutics has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in December 2022. The round record for Carrick Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Rosetta Capital, Lightstone Ventures, Google Ventures, Cambridge Innovation Capital, Evotec and 1 others. 7 distinct backers are named across the disclosed rounds.
Carrick Therapeutics at a glance
Total raised
$60M
Latest round
Series C
Latest round date
December 2022
Headquarters
Dublin, Ireland
Notable investors
ARCH Venture Partners, Rosetta Capital, Lightstone Ventures, Google Ventures, Cambridge Innovation Capital, Evotec, Pfizer Inc.
Frequently asked about Carrick Therapeutics funding
How much has Carrick Therapeutics raised?
Carrick Therapeutics has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Carrick Therapeutics?
ARCH Venture Partners, Rosetta Capital, Lightstone Ventures, Google Ventures, Cambridge Innovation Capital, Evotec are named among the investors backing Carrick Therapeutics.
What was the latest Carrick Therapeutics funding round?
The most recent disclosed round is a Series C, announced in December 2022.
Where is Carrick Therapeutics based?
Carrick Therapeutics is based in Dublin, Ireland.
When did Carrick Therapeutics last raise?
The last disclosed Carrick Therapeutics round closed in December 2022 at Series C.
Carrick Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Dublin below to benchmark round size and investor mix.
